DWAHF yields 2.83% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, DWAHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DWAHF + PFE for your $10,000?
Daiwa House Industry Co., Ltd. engages in the construction business worldwide. It operates through Single-Family Houses; Rental Housing; Condominiums; Existing Homes; Commercial Facilities; Logistics, Business and Corporate Facilities; and Other Businesses segments. The company constructs single-family houses; rents houses; develops, manages, and sells condominiums; purchases, renovates, and resells existing homes; develops commercial facilities; develops and constructs logistics, business, and corporate facilities; and provides real estate agency services. It also manufactures steel and timber housing parts; offers ground survey and reinforcement services; and constructs retail and wholesale, medical and nursing care, office and factory, urban development and industrial park, energy, environmental greening, agriculture, parking and carsharing, and public-private partnership facilities. In addition, the company operates resort hotels and golf courses, business and city hotels, fitness clubs and aesthetic salons, and home centers; provides robotics technologies for use in hospitals, care facilities, factories, and construction sites; manages private homes for the elderly and assisted-living residential facilities for seniors; and offers parking, advertising, travel agency, information technology, and credit card and insurance agency services. Daiwa House Industry Co., Ltd. was incorporated in 1947 and is headquartered in Osaka, Japan.
Full DWAHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.